Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iqvia Holdings Inc (NY: IQV )

242.12 -2.50 (-1.02%)
Official Closing Price Updated: 7:00 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Iqvia Holdings Inc

< Previous 1 2 3 4 5 Next >
IQVIA Reports Third-Quarter 2023 Results
From IQVIA
Via Business Wire
IQVIA to Provide Sanofi Its Orchestrated Customer Engagement (OCE) Platform in Africa & Middle East
From IQVIA
Via Business Wire
IQVIA and CEPI Collaborate to Strengthen Global Research Preparedness to Advance the 100 Days Mission
From IQVIA
Via Business Wire
IQVIA to Announce Third-Quarter 2023 Results on November 1, 2023
From IQVIA
Via Business Wire
Patient Organizations Gave $22 Billion in Grants for Research, Patient Services, and Access to Care Over the Last 5 Years, Says IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
IQVIA Builds on its Strategic Collaboration with argenx to Provide Safety Systems and Services
From IQVIA
Via Business Wire
IQVIA Appoints Richard Staub III President of Research & Development Solutions
From IQVIA
Via Business Wire
IQVIA Named a Leader in Pharmacovigilance Solutions in IDC MarketScape Report
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference on September 13, 2023
From IQVIA Holdings Inc.
Via Business Wire
IQVIA CEO Ari Bousbib to Speak at Morgan Stanley Annual Global Healthcare Conference on September 12, 2023
From IQVIA
Via Business Wire
IQVIA Reports Second-Quarter 2023 Results
From IQVIA Holdings Inc.
Via Business Wire
IQVIA to Announce Second-Quarter 2023 Results on August 1, 2023
From IQVIA Holdings Inc.
Via Business Wire
IQVIA and the NBA Selected for Abbott’s UNIVANTS of Healthcare Excellence Award
From IQVIA
Via Business Wire
IQVIA selected ‘Leader’ in Everest Group Life Sciences Sales and Marketing Operations PEAK Matrix® Assessment 2023
From IQVIA
Via Business Wire
IQVIA Wins Prestigious “Best AI-based Solution for Healthcare” Award in 2023 Artificial Intelligence Breakthrough Awards
From IQVIA
Via Business Wire
IQVIA Launches RIM Smart Labeling to Deliver Intelligence-Driven Approach for Global Label Management
From IQVIA
Via Business Wire
IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
From IQVIA
Via Business Wire
Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Announces Offering of Senior Secured Notes and Senior Notes
From IQVIA
Via Business Wire
IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award
From IQVIA
Via Business Wire
Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute
From IQVIA
Via Business Wire
IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023
From IQVIA
Via Business Wire
IQVIA to Announce First-Quarter 2023 Results on April 27, 2023
From IQVIA Holdings Inc.
Via Business Wire
Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023
From IQVIA
Via Business Wire
IQVIA Publishes its 2022 Environmental, Social and Governance Report
From IQVIA
Via Business Wire
IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Named to FORTUNE’s 2023 List of “World’s Most Admired Companies,” Ranked #1 in Its Category for the Second Consecutive Year
From IQVIA
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.